Package leaflet: Information for the user. Fleet Phospho-soda 24.4 g / 10.8 g oral solution

Similar documents
PACKAGE LEAFLET: INFORMATION FOR THE USER. PEGLAX 10g Powder for oral solution in sachet. Macrogol 4000

Package Leaflet: Information for the User

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

Package leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free

PACKAGE LEAFLET: INFORMATION FOR THE USER. Fleet Ready-to-Use 21.4g/9.4g Enema Sodium Dihydrogen Phosphate Dihydrate / Disodium Phosphate Dodecahydate

Plenvu powder for oral solution Macrogol 3350, sodium ascorbate, sodium sulfate anhydrous, ascorbic acid, sodium chloride and potassium chloride.

Package Leaflet: Information for the patient. Movicol Ready to Take oral solution in sachet

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

1. What Miacalcic is and what it is used for

Imodium 1 mg/5 ml oral solution

1. What Octostim Nasal Spray is and what it is used for

Package leaflet: Information for the user

Package leaflet: Information for the user. Reminyl 4 mg/ml oral solution. galantamine

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

Package leaflet: Information for the patient. Pikopil druppels voor oraal gebruik, oplossing, 7.5 mg/ml. Sodium picosulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the user. Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate.

Dulcolax 5 mg, film-coated tablets

Package leaflet: Information for the User. Moviprep Orange, powder for oral solution

Ventolin Injection 500 micrograms/ml salbutamol sulfate

If you need the information on this leaflet in an alternative format, such as large text, or Braille please ring from the UK:

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

PACKAGE LEAFLET: INFORMATION FOR THE USER

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

2. What you need to know before you take DDAVP/Desmopressin Tablets

Package leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

PACKAGE LEAFLET: INFORMATION FOR THE USER

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

Package leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride

Irbenida H 150mg/12,5mg film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

Package Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package leaflet: Information for the user. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate

Read all of this leaflet carefully before you start taking this medicine

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

PACKAGE LEAFLET: INFORMATION FOR THE USER

Fultium can also be used as an adjunct to specific bone loss medication

SIOFOR mg film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

Package leaflet: Information for the user. GLUCOPHAGE 500 mg powder for oral solution in sachets metformin hydrochloride

Package leaflet: Information for the patient

What is in this leaflet

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Otrivin Menthol (without preservative) 1 mg/ml nasal spray, solution Xylometazoline hydrochloride

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

PACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE REGULAX PICOSULFATE LAXATIVE CUBES

THORENS I.U. /ml oral drops, solution Cholecalciferol (vitamin D 3 )

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Reference ID:

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate

Package leaflet: Information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

Ventolin Accuhaler 200 micrograms salbutamol sulfate

PATIENT INFORMATION LEAFLET. Testosterone Enantate 250mg/ ml Solution for Injection Testosterone Enantate

Package Leaflet: Information for the Patient. FOSRENOL 750 mg oral powder. FOSRENOL 1000 mg oral powder. lanthanum

Package Leaflet: Information for the User. Zomig Rapimelt 2.5 mg and 5 mg orodispersible tablets zolmitriptan

PACKAGE LEAFLET: INFORMATION FOR THE USER. Folic Acid 2.5mg/5ml Oral Solution Folic Acid 2.5mg/5ml

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulphate

Package Leaflet: INFORMATION FOR THE USER. PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide)

Some general information on hepatitis A infection is given at the end of this leaflet.

Motens 2 mg and 4 mg Tablets lacidipine

Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)

Package leaflet: Information for the user. Zonnic Mint 2 mg oromucosal powder in pouch Nicotine

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

PACKAGE LEAFLET: INFORMATION FOR THE USER Meronem IV 500 mg and 1 g Powder for solution for injection or infusion meropenem

1 What Engerix B is and what it is used for

SINGULAIR JUNIOR 5mg chewable tablets

Package leaflet: Information for users. Imodium 2 mg orodispersible tablets Loperamide hydrochloride

Pravat 40 mg tablets. Pravastatin sodium

Package leaflet: Information for the user

Package Leaflet: Information for the Patient. FOSRENOL 750 mg chewable tablets. FOSRENOL 1000 mg chewable tablets. lanthanum

Patient Information Leaflet MOVICOL Paediatric Plain 6.9g sachet, powder for oral solution

Transcription:

PACKAGE LEAFLET 1

Package leaflet: Information for the user Fleet Phospho-soda 24.4 g / 10.8 g oral solution Sodium Dihydrogen Phosphate Dihydrate / Disodium Phosphate Dodecahydrate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. This medicine is available without prescription. However, you still need to use Fleet Phospho-soda carefully to get the best results from it. Always take this medicine exactly as described in this leaflet or as your doctor, pharmacist or nurse have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Fleet Phospho-soda is and what it is used for 2. What you need to know before you take Fleet Phospho-soda 3. How to take Fleet Phospho-soda 4. Possible side effects 5. How to store Fleet Phospho-soda 6. Contents of the pack and other information 1. What Fleet Phospho-Soda is and what it is used for Fleet Phospho-soda is a bowel cleanser that acts by increasing the water content of your stools. It is a solution which you take by mouth and it comes in packs containing two 45 ml bottles. Each bottle contains one dose which must be diluted with water before use (see Section 3). You need to take Fleet Phospho-soda in order to clean your bowel (also called large intestine or colon) before your endoscopy, bowel surgery or X-ray examination. It is important that your bowel is completely empty so that the doctors can see it clearly. Fleet Phospho-soda is not a treatment for constipation. 2. What you need to know before you take Fleet Phospho-Soda Do not take Fleet Phospho-soda if you: are allergic to disodium phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate or any of the other ingredients of this medicine (listed in section 6); are under the age of 18 years; feel sick or are vomiting, or are suffering from abdominal pains; have kidney failure; suffer from congestive heart failure; have an abnormal build up of fluid in the space between the lining of the abdomen and the abdominal organs; know or suspect you have an obstruction, perforation or paralysis of your bowels; have inherited or acquired enlargement of the large intestine (megacolon); suffer from active inflammatory bowel disease; have overactive parathyroid glands (hyperparathyroidism) ; 2

Do not take Fleet Phospho-soda in combination with any other laxative products containing sodium phosphate. Check with your doctor if you think any of the above could apply to you. Your doctor will then decide if Fleet Phospho-soda is suitable for you. Warnings and precautions Talk to your doctor, pharmacist or nurse before taking Fleet Phospho-soda Take special care with Fleet Phospho-soda if you: are frail or elderly (65 years old or more); have a heart or kidney condition; suffer from changes to levels of salts in your body (electrolyte imbalances) or are at risk of such changes, for example if you are dehydrated. have low blood pressure or reduced movement in part or all of your intestines; have had a colostomy or an ileostomy; have had any other kind of operation or surgery on your stomach or intestines; are on a low-sodium (low-salt) diet (See also section Important information about some of the ingredients of Fleet Phospho-soda ). Please consult your doctor, if you think any of the statements above are applicable to you now or at any time in the past. Fleet Phospho-soda could slightly alter the rhythm of the heart as a result of electrolyte imbalances, so you may need closer medical supervision during your treatment. After taking Fleet Phospho-soda you should expect to produce frequent, liquid stools. You should drink as much clear liquid (see Section 3) as possible so that you do not become dehydrated. This product usually works within 30 minutes to 6 hours. If you have no bowel movement within 6 hours of taking either the first or the second dose, contact a doctor immediately because you could become dehydrated. Other medicines and Fleet Phospho-soda Before taking Fleet Phospho-soda you must tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, especially: medicines for the treatment of high blood pressure (hypertension) or angina (calcium channel blockers); medicines for emptying the bladder (diuretics); non steroidal anti-inflammatory drugs (NSAIDs) such as aspirin; certain medicines for mental disorders (containing lithium); any other medicines that could make you dehydrated or change various salt levels (potassium, sodium, phosphate or water) in your body (your electrolyte balance); medicines that alter the rhythm of your heart; parathyroid hormone medicines; medicines regularly taken by mouth: for example, oral contraceptives, and medicines for epilepsy or diabetes or antibiotics, because Fleet Phospho-soda may delay or completely prevent the absorption of these oral medicines, making them less effective or ineffective. Check with your doctor or pharmacist, if you are unsure. Fleet Phospho-soda with food and drink Please see Section 3 of this leaflet. 3

Pregnancy and breast-feeding If you are pregnant or or breast-feeding think you may be pregnant or are planning to have a baby,ask your doctor for advice before taking Fleet Phospho-soda. You should not use this medicine during pregnancy unless your doctor considers it necessary. If you are breast-feeding, you should not breast-feed your child for 24 hours after taking the second dose of Fleet Phospho-soda. Frail people and the elderly (65 years of age and over): Please pay special attention to the advice given in the sub-sections Take special care with Fleet Phosphosoda and Taking other medicines (above) as well as to the instructions on How to take this medicine in Section 3 (below). It may be that you will need special medical supervision. Driving and using machines Do not drive, use machinery or tools if you feel tired or dizzy, or think you may be dehydrated, after taking Fleet Phospho-soda. You should also stay within easy reach of toilet facilities after taking this medicine. Fleet Phospho-soda contains sodium Fleet Phospho-soda contains 5.0 g sodium in each 45 ml dose. Consideration should therefore be given to the potential harm to patients requiring a low-sodium (low-salt) diet. This medicinal product also contains a very small amount of ethanol (alcohol), less than 100 mg per dose. 3. How to take Fleet Phospho-Soda Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure. Before you first start taking Fleet Phospho-soda up until after your examination, it is important that you drink only clear liquid. Do not eat any solid food. Clear liquid means water; clear soup, or soup that has been strained to remove any solids; fruit juices without pulp (but not red or purple juices); black tea or black coffee and clear fizzy/non fizzy drinks e.g. lemonade. To help prevent you feeling sick while taking this medicine, you should drink as much clear liquid as you can. Fleet Phospho-soda may cause a number of diarrhoea-like bowel movements. It often starts to work within 30 minutes and may go on working for up to 6 hours. Please stay within easy reach of a toilet until your bowel movements have stopped. If you have had no bowel movement within 6 hours of taking either the first dose or the second dose, you must contact a doctor immediately, because you could become dehydrated. You must start taking Fleet Phospho-soda the day before your hospital appointment. How to take your first or second dose To do this, dilute the contents of one bottle (45 ml) of Fleet Phospho-soda in half a glass (120 ml) of cold water. Drink this and follow it with at least one full glass (240 ml) of cold water. Drink as much clear liquid as possible to replace the fluids lost during bowel movements. When to take your first or second dose Please refer to the two boxes below, depending on the time of your hospital appointment. If you do not follow these instructions completely, it may not be possible to proceed with your examination or surgery. MORNING APPOINTMENTS 8.00 A.M. 12 NOON 4

THE DAY BEFORE YOUR APPOINTMENT At 7a.m. drink at least one full glass (240 ml) of clear liquid for breakfast. You may drink more if you wish. Straight afterwards take your first dose. (See above). At 1p.m. drink at least three more full glasses (720 ml) of clear liquid for lunch. During the afternoon, you may continue to drink clear liquid to satisfy your thirst. At 7p.m. drink at least one full glass (240 ml) of clear liquid for supper. You may drink more if you wish. Straight afterwards take your second dose. (See above). You may continue to drink clear liquid up until midnight to satisfy your thirst. Clear liquid taken after midnight may cause further visits to the toilet resulting in sleep loss. AFTERNOON APPOINTMENTS 12 NOON 5.00P.M. THE DAY BEFORE YOUR APPOINTMENT At 1p.m. eat a light snack, e.g. soup and a sandwich for lunch. Do not eat any more solid food until after your hospital appointment. During the afternoon, you may drink clear liquid to satisfy your thirst. At 7p.m. drink at least one full glass (240 ml) of clear liquid for supper. You may drink more if you wish. Straight afterwards take your first dose. (See above). During the evening, make sure you drink at least three more full glasses (720 ml) of water or clear liquid before going to bed. THE DAY OF YOUR APPOINTMENT At 7a.m. drink at least one full glass of clear liquid for breakfast. You may drink more if you wish. Straight afterwards take your second dose. (See above). You may continue to drink clear liquid up until 8a.m. to satisfy your thirst. Clear liquid taken after 8a.m. may cause further visits to the toilet resulting in difficulties in getting to your hospital appointment. After your hospital appointment, make sure you drink plenty of fluid to replace fluid lost when you were taking Fleet Phospho-soda. If you take more Fleet Phospho-soda than you should If you may have taken more Fleet Phospho-soda than you should, talk to a doctor or pharmacist immediately, because you may be dehydrated, have problems with your heart and circulation, have breathing difficulties, feel anxious or have colic pain. If you forget to take Fleet Phospho-soda Please consult your doctor for advice. Do not take a double dose to make up for a forgotten dose. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Very rarely, Fleet Phospho-soda can cause serious allergic reactions with or without a rash. Tell your doctor immediately or contact the emergency department of your nearest hospital if your hands, face, lips, throat or tongue start to swell, or if you have difficulty in breathing or swallowing. 5

Other possible side effects with Fleet Phospho-soda: Very common (affects more than 1 user in 10): feeling sick, abdominal pain, bloating and diarrhoea, chills, weakness and dizziness. Common (affects 1 to 10 users in 100): Vomiting, chest pain and headache. Uncommon (affects 1 to 10 users in 1,000): Dehydration Rare (affects 1 to 10 users in 10,000): A build up of calcium in the kidneys Very rare (affects less than 1 user in 10,000): Heart attack, palpitations, low blood pressure, changes in the amounts of salts (electrolytes) in the blood (which may lead to twitches and spasms), muscle cramps, pins and needles, loss of consciousness, and kidney failure. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Fleet Phospho-Soda Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the pack after EXP. The expiry date refers to the last day of that month. Do not store above 25 C. Once opened, use immediately. Discard any unused solution. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 6. Contents of the pack and other information What Fleet Phospho-soda contains The active substances are Sodium Dihydrogen Phosphate Dihydrate 24.4 g and Disodium Phosphate Dodecahydrate 10.8 g in each 45 ml dose. The other ingredients are: Sodium Benzoate (E211); Sodium Saccharin; Glycerol; Purified Water and Ginger Lemon flavour comprising of Oleoresin Ginger; Alcohol; Oil Lemon; Partially Deterpinated Oil Lemon; Citric Acid and Purified Water. What Fleet Phospho-soda looks like and contents of the pack Fleet Phospho-soda is a clear colourless oral solution with a ginger-lemon odour, which comes in packs containing 2 or 100 45 ml bottles with screw caps. Each bottle contains one dose. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer: Casen Recordati, S.L., Autovia de Logroño, km 13,300, 50180 Utebo, Zaragoza, Spain. 6

If you have any questions or comments about this product, please contact us on: enquiries@casenrecordati.com This medicinal product is authorised in the Member States of the EEA under the following names: Denmark: Phosphoral oral opløsning Finland: Phosphoral oraaliliuos France: Fleet Phospho-Soda, solution buvable Germany: Fleet Phospho-soda Lösung zum Einnehmen Greece: Fleet Phospho-soda Ireland: Fleet Phospho-soda oral solution Netherlands: Phosphoral, drank Portugal: Fleet Phospho-Soda Solução oral Spain: Fosfosoda solución oral Sweden: Phosphoral oral lösning United Kingdom: Fleet Phospho-soda oral solution This leaflet was last revised in 17.06.2015 7